AVP-893

N/A

Report date: 2024/01/25 09:18:01
NME

Base Information

Drug NameAVP-893
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressantsImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsHypersensitivityAsthmaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvanir Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvanir Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthmaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A